Microbial community and metabolomic comparison of irritable bowel syndrome faeces

Journal of Medical Microbiology

Volumn 60, Issue 6, 2011, Pages 817-827

  Ponnusamy, Kannan ^a   Choi, Jung Nam ^a   Kim, Jiyoung ^a   Lee, Sun Young ^b   Lee, Choong Hwan ^a  

^a Konkuk University   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ATROLACTIC ACID; MANDELIC ACID; PHENOL DERIVATIVE; PYROGLUTAMIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL COUNT; BACTEROIDETES; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA EXTRACTION; ENERGY METABOLISM; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; MICROBIAL DIVERSITY; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AMINO ACIDS; BACTERIA; BIODIVERSITY; CLUSTER ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA, BACTERIAL; DNA, RIBOSOMAL; FECES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; METABOLOME; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOLS; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 79957601426     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.028126-0     Document Type: Article

References (37)

1. Apajalahti, J. H., Sarkilahti, L. K., Maki, B. R., Heikkinen, J. P., Nurminen, P. H. & Holben, W. E. (1998). Effective recovery of bacterial DNA and percent-guanine-plus-cytosine-based analysis of community structure in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol 64, 4084-4088.
2. Benno, Y., Endo, K., Mizutani, T., Namba, Y., Komori, T. & Mitsuoka, T. (1989). Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 55, 1100-1105.
3. Codling, C., O'Mahony, L., Shanahan, F., Quigley, E. M. & Marchesi, J. R. (2010). A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 55, 392-397.
4. De Vos, W. M. (2005). Lipotechoic acid in lactobacilli: D-alanine makes the difference. Proc Natl Acad Sci USA 102, 10763-10764.
5. Engberg, R. M., Hedemann, M. S., Leser, T. D. & Jensen, B. B. (2000). Effect of zinc bacitracin and salinomycin on intestinal microflora and performance of broilers. Poult Sci 79, 1311-1319.
6. Gao, X., Pujos-Guillot, E., Martin, J. F., Galan, P., Juste, C., Jia, W. & Sebedio, J. L. (2009). Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate deriva-tization. Anal Biochem 393, 163-175.
7. Han, S. H., Lee, O. Y., Bae, S. C., Lee, S. H., Chang, Y. K., Yang, S. Y., Yoon, B. C., Choi, H. S., Hahm, J. S. & other authors (2006). Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol 21, 1687-1692.
8. Harrington, C. R., Lucchini, S., Ridgway, K. P., Wegmann, U., Eaton, T. J., Hinton, J. C., Gasson, M. J. & Narbad, A. (2008). A short-oligonucleotide microarray that allows improved detection of gastrointestinal tract microbial communities. BMC Microbiol 8, 195.
9. Heavey, P. M. & Rowland, I. R. (1999). The gut microflora of the developing infant: microbiology and metabolism. Microb Ecol Health Dis 11, 75-83.
10. Kajander, K., Myllyluoma, E., Kyronpalo, S., Rasmussen, M., Sipponen, P., Mattila, I., Seppanen-Laakso, T., Vapaatalo, H., Oresic, M. & Korpela, R. (2009). Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 15, 6068-6074.
11. Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L., Makivuokko, H., Kajander, K. & Palva, A. (2009). Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9, 95.
12. Lara-Villoslada, F., De Haro, O., Camuesco, D., Comalada, M., Velasco, J., Zarzuelo, A., Xaus, J. & Galvez, J. (2006). Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr 45, 418-425.
13. Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Shen, J., Pang, X. & other authors (2008). Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105, 2117-2122.
14. Matsuki, T., Watanabe, K., Fujimoto, J., Miyamoto, Y., Takada, T., Matsumoto, K., Oyaizu, H. & Tanaka, R. (2002). Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68, 5445-5451.
15. Mortensen, P. B., Andersen, J. R., Arffmann, S. & Krag, E. (1987). Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 22, 185-192.
16. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C. & other authors (2006). Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
17. Muyzer, G. & Smalla, K. (1998). Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electro-phoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek 73, 127-141.
18. Nam, Y.-D., Chang, H.-W., Kim, K.-H., Roh, S. W., Kim, M.-S., Jung, M.-J., Lee, S.-W., Kim, J.-Y., Yoon, J.-H. & Bae, J.-W. (2008). Bacterial, archaeal, and eukaryal diversity in the intestines of Korean people. J Microbiol 46, 491-501.
19. Ohman, L. & Simren, M. (2007). New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 39, 201-215.
20. Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Folsch, U. R., Timmis, K. N. & Schreiber, S. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693.
21. Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S. & Flint, H. J. (2002). The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133-139.
22. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F. & other authors (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
23. Rajilic-Stojanovic, M., Smidt, H. & De Vos, W. M. (2007). Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 9, 2125-2136.
24. Rehman, A., Lepage, P., Nolte, A., Hellmig, S., Schreiber, S. & Ott, S. J. (2010). Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 59, 1114-1122.
25. Rinttilä, T., Kassinen, A., Malinen, E., Krogius, L. & Palva, A. (2004). Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97, 1166-1177.
26. Romick-Rosendale, L. E., Goodpaster, A. M., Hanwright, P. J., Patel, N. B., Wheeler, E. T., Chona, D. L. & Kennedy, M. A. (2009). NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem 47 (Suppl. 1), S36- S46.
27. Saggioro, A. (2004). Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38 (Suppl.), S104-S106.
28. Salonen, A., De Vos, W. M. & Palva, A. (2010). Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156, 3205-3215.
29. Scanlan, P. D., Shanahan, F., O'Mahony, C. & Marchesi, J. R. (2006). Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 44, 3980-3988.
30. Scherling, C., Roscher, C., Giavalisco, P., Schulze, E. D. & Weckwerth, W. (2010). Metabolomics unravel contrasting effects of biodiversity on the performance of individual plant species. PLoS ONE 5, e12569.
31. Schwiertz, A., Jacobi, M., Frick, J. S., Richter, M., Rusch, K. & Kohler, H. (2010). Microbiota in pediatric inflammatory bowel disease. J Pediatr 157, 240-244.e1.
32. Tana, C., Umesaki, Y., Imaoka, A., Handa, T., Kanazawa, M. & Fukudo, S. (2010). Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22, 512-519, e114-e115.
33. Vanhoutte, T., Huys, G., Brandt, E. & Swings, J. (2004). Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48, 437- 446.
34. Walter, J., Hertel, C., Tannock, G. W., Lis, C. M., Munro, K. & Hammes, W. P. (2001). Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67, 2578-2585.
35. Winter, J., Popoff, M. R., Grimont, P. & Bokkenheuser, V. D. (1991). Clostridium orbiscindens sp. nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring. Int J Syst Bacteriol 41, 355-357.
36. Woodmansey, E. J., McMurdo, M. E., Macfarlane, G. T. & Macfarlane, S. (2004). Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 6113-6122.
37. Zwielehner, J., Liszt, K., Handschur, M., Lassl, C., Lapin, A. & Haslberger, A. G. (2009). Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44, 440-446.